Baqsimi Europeiska unionen - svenska - EMA (European Medicines Agency)

baqsimi

eli lilly nederland b.v. - glukagon - diabetes mellitus - pankreas hormoner, hormoner glycogenolytic - baqsimi är indicerat för behandling av svår hypoglykemi hos vuxna, ungdomar och barn i åldrarna 4 år och äldre med diabetes mellitus.

Retsevmo Europeiska unionen - svenska - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiska medel - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Rayvow Europeiska unionen - svenska - EMA (European Medicines Agency)

rayvow

eli lilly nederland b.v. - lasmiditan succinate - migrän störningar - smärtstillande medel - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

Omvoh Europeiska unionen - svenska - EMA (European Medicines Agency)

omvoh

eli lilly nederland b.v. - mirikizumab - kolit, ulcerativ - immunsuppressiva - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

Jaypirca Europeiska unionen - svenska - EMA (European Medicines Agency)

jaypirca

eli lilly nederland b.v. - pirtobrutinib - lymfom, mantelcell - protein kinas-hämmare - treatment of mantle cell lymphoma (mcl).